---
authors:
- Ebell, Mark H
category: Case Study
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/39823623/
file_path: 2025/01/sglt-2-inhibitors-reduce-cardiovascular-mortality-but-benefi.md
issue: '1'
last_updated: '2025-07-30'
original_format: PubMed
pages: '84'
patient_population: Adults
peer_reviewed: true
pmid: '39823623'
processed_date: '2025-07-30'
publication_date: '2025-01-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: SGLT-2 Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest, Even
  in Patients With Established Heart Disease.
topics:
- Family Medicine
volume: '111'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '39823623'
  title: SGLT-2 Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest,
    Even in Patients With Established Heart Disease.
  authors:
  - last_name: Ebell
    fore_name: Mark H
    initials: MH
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '111'
    issue: '1'
  publication_info:
    year: '2025'
    month: '01'
    full_date: '2025-01-01'
  article_ids: {}
  publication_types: *id001
---

# SGLT-2 Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest, Even in Patients With Established Heart Disease.

**Authors:** Ebell, Mark H

**Published in:** American family physician | Vol. 111, No. 1 | 2025-01-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/39823623/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/39823623/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
